Catalyst Pharmaceuticals Reports Record First Quarter 2023 Results, Achieving 98% Total Revenue Growth Year-over-Year

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. SPCX
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Catalyst Pharmaceuticals Reports Record First Quarter 2023 Results, Achieving 98% Total Revenue Growth Year-over-Year

Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 9c

May 10, 2023 4:35 PM EDT

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.41, $0.09 better than the analyst estimate of $0.32. Revenue for the quarter came in at $85.4 million versus the consensus estimate of $81.62 million.

GUIDANCE:

Catalyst Pharmaceuticals sees FY2023 revenue of $195-205 million, versus the consensus of... More